Insider Transactions Reported by 15 Insiders of Q/C TECHNOLOGIES, INC.

Symbol
QCLS on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

Q/C TECHNOLOGIES, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chelsea Sierra Voss Director $1,246,760 16 Jan 2026
Paul Rivard Chief Legal Officer $444,000 24 Aug 2023
Joshua N. Silverman Executive Chairman, Director $435,126 14 Nov 2025
Bruce Bernstein Director $108,750 14 Nov 2025
Stephen Friscia Director $108,750 14 Nov 2025
Billy Joe White Director $84,581 14 Nov 2025
Gary M. Rauch Vice President of Finance $54,375 14 Nov 2025
Mitchell Glass Director, Chief Medical Off., Director $42,250 14 Nov 2025
Craig Eagle Director 07 Jun 2023
Adam Kaplin Chief Scientific Officer 07 Jun 2023
Christopher Chapman MD President, Chief Med. Officer, Director 07 Jun 2023
Jude Uzonwanne Director 07 Jun 2023
Christopher C. Schreiber Director 07 Jun 2023
PharmaCyte Biotech, Inc. 10%+ Owner 04 Sep 2025
Ian Rhodes Interim CFO 17 Apr 2025

Recent Insider Transactions by Companies or Individuals for Q/C TECHNOLOGIES, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Chelsea Sierra Voss QCLS Common stock Award 9895.8% 237,500 239,900 16 Jan 2026 Direct
Chelsea Sierra Voss QCLS Employee Stock Option (Right to Buy) Award 212,500 212,500 16 Jan 2026 Direct
PharmaCyte Biotech, Inc. TNFA Warrants Purchase 889,865 889,865 14 Nov 2025 Direct
Mitchell Glass TNFA Common stock Award 1057.4% 11,420 12,500 14 Nov 2025 Direct
Billy Joe White TNFA Common stock Award 1045.3% 22,839 25,024 14 Nov 2025 Direct
Joshua Silverman TNFA Common stock Award 1053.3% 91,356 100,029 14 Nov 2025 Direct
Stephen Friscia TNFA Common stock Award 1056.9% 22,839 25,000 14 Nov 2025 Direct
Bruce Bernstein TNFA Common stock Award 25,000 25,000 14 Nov 2025 Direct
Gary M. Rauch TNFA Common stock Award 1057.4% 11,420 12,500 14 Nov 2025 Direct
Joshua Silverman TNFA Common stock Award 29806.9% 8,644 8,673 03 Oct 2025 Direct
Stephen Friscia TNFA Common stock Award 2,161 2,161 03 Oct 2025 Direct
Mitchell Glass TNFA Common stock Award 1,080 1,080 03 Oct 2025 Direct
Billy Joe White TNFA Common stock Award 9004.2% 2,161 2,185 03 Oct 2025 Direct
Gary M. Rauch TNFA Common stock Award 1,080 1,080 03 Oct 2025 Direct
PharmaCyte Biotech, Inc. TNFA Series H Convertible Preferred Stock Purchase 889,865 889,865 04 Sep 2025 Direct
Gary M. Rauch TNFA Employee Stock Option (Right to Buy) Award 75,000 75,000 17 Apr 2025 Direct
Ian Rhodes TNFA Employee Stock Option (Right to Buy) Award 25,000 25,000 17 Apr 2025 Direct
Mitchell Glass TNFA Employee Stock Option (Right to Buy) Award 125,000 125,000 17 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.